First American Bank Purchases New Position in Agilent Technologies, Inc. $A

Key Points

• First American Bank has acquired a new position in Agilent Technologies, purchasing 4,644 shares for approximately $548,000 in the second quarter.
• Agilent Technologies reported a quarterly revenue of $1.74 billion, exceeding analysts' expectations, alongside earnings per share of $1.37 for the same quarter.
• The company announced a quarterly dividend of $0.248 per share, payable on October 22nd, with an annualized dividend yield of 0.8%.

First American Bank purchased a new stake in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 4,644 shares of the medical research company's stock, valued at approximately $548,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Patton Fund Management Inc. bought a new stake in shares of Agilent Technologies during the second quarter valued at approximately $244,000. Novem Group boosted its holdings in Agilent Technologies by 4.1% in the second quarter. Novem Group now owns 8,381 shares of the medical research company's stock worth $989,000 after purchasing an additional 328 shares during the last quarter. Cardinal Capital Management boosted its holdings in Agilent Technologies by 4.6% in the second quarter. Cardinal Capital Management now owns 73,561 shares of the medical research company's stock worth $8,681,000 after purchasing an additional 3,236 shares during the last quarter. Occidental Asset Management LLC boosted its holdings in Agilent Technologies by 7.3% in the second quarter. Occidental Asset Management LLC now owns 27,263 shares of the medical research company's stock worth $3,217,000 after purchasing an additional 1,847 shares during the last quarter. Finally, Gries Financial LLC purchased a new stake in Agilent Technologies in the second quarter worth approximately $292,000.

Agilent Technologies Trading Up 1.3%

Shares of Agilent Technologies stock opened at $123.45 on Friday. The company's fifty day simple moving average is $121.15 and its 200-day simple moving average is $115.95. The stock has a market capitalization of $35.00 billion, a PE ratio of 28.98, a P/E/G ratio of 3.98 and a beta of 1.24. Agilent Technologies, Inc. has a 1-year low of $96.43 and a 1-year high of $153.84. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.25 and a quick ratio of 1.71.

Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, hitting the consensus estimate of $1.37. The business had revenue of $1.74 billion for the quarter, compared to analysts' expectations of $1.67 billion. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The company's revenue was up 10.1% compared to the same quarter last year. During the same quarter last year, the company posted $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. As a group, equities analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 22nd. Investors of record on Tuesday, September 30th will be paid a dividend of $0.248 per share. The ex-dividend date is Tuesday, September 30th. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.8%. Agilent Technologies's payout ratio is 23.24%.

Insider Buying and Selling at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,508 shares of Agilent Technologies stock in a transaction on Tuesday, July 1st. The shares were sold at an average price of $117.44, for a total transaction of $177,099.52. Following the transaction, the chief executive officer owned 37,448 shares in the company, valued at approximately $4,397,893.12. The trade was a 3.87% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Analyst Ratings Changes

Several equities research analysts recently issued reports on A shares. Wells Fargo & Company raised their target price on shares of Agilent Technologies from $140.00 to $150.00 and gave the stock an "overweight" rating in a report on Monday, September 15th. Evercore ISI dropped their target price on shares of Agilent Technologies from $130.00 to $128.00 and set an "in-line" rating on the stock in a report on Thursday, August 28th. Robert W. Baird raised their target price on shares of Agilent Technologies from $141.00 to $142.00 and gave the stock an "outperform" rating in a report on Thursday, August 28th. Barclays restated an "equal weight" rating and issued a $125.00 target price on shares of Agilent Technologies in a report on Friday, August 29th. Finally, Leerink Partners lifted their price target on shares of Agilent Technologies to $135.00 and gave the stock a "buy" rating in a research note on Friday, May 30th. Six analysts have rated the stock with a Buy rating and six have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $140.08.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.